Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Sex Transm Dis ; 40(2): 148-53, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23324977

RESUMO

BACKGROUND: Identifying sexually transmitted infections (STI) in HIV-infected individuals has potential to benefit individual and public health. There are few guidelines regarding routine STI screening in sub-Saharan African HIV programs. We determined sexual risk behavior and prevalence and correlates of STI in a national survey of large HIV treatment programs in Kenya. METHODS: A mobile screening team visited 39 (95%) of the 42 largest HIV care programs in Kenya and enrolled participants using population-proportionate systematic sampling. Participants provided behavioral and clinical data. Genital and blood specimens were tested for trichomoniasis, gonorrhea, chlamydia, syphilis, and CD4 T-lymphocyte counts. RESULTS: Among 1661 adults, 41% reported no sexual partners in the past 3 months. Among those who reported sex in the past 3 months, 63% of women reported condom use during this encounter compared with 77% of men (P < 0.001). Trichomoniasis was the most common STI in women (10.9%) and men (2.8%); prevalences of gonorrhea, chlamydia, and syphilis were low (<1%-2%). Among women, younger age (adjusted odds ratio [OR], 0.96 per year; 95% confidence interval [CI], 0.94-0.98) and primary school education or lower level (adjusted OR, 2.16; 95% CI, 1.37-3.40) were independently associated with trichomoniasis, whereas CD4 count, cotrimoxazole use, and reported condom use were not. Reported condom use at last sex was associated with reporting that the clinic provided condoms among both women (OR, 1.7; 95% CI, 1.17-2.35) and men (OR, 2.4; 95% CI, 1.18-4.82). CONCLUSIONS: Women attending Kenyan HIV care programs had a 10.9% prevalence of trichomoniasis, suggesting that screening for this infection may be useful. Condom provision at clinics may enhance secondary HIV prevention efforts.


Assuntos
Infecções por Chlamydia/prevenção & controle , Gonorreia/prevenção & controle , Infecções por HIV/prevenção & controle , Comportamento Sexual , Sífilis/prevenção & controle , Tricomoníase/prevenção & controle , Adolescente , Adulto , Idoso , Instituições de Assistência Ambulatorial , Contagem de Linfócito CD4 , Infecções por Chlamydia/epidemiologia , Feminino , Gonorreia/epidemiologia , Guias como Assunto , Infecções por HIV/epidemiologia , Educação em Saúde , Humanos , Quênia/epidemiologia , Masculino , Pessoa de Meia-Idade , Prevalência , Avaliação de Programas e Projetos de Saúde , Fatores de Risco , Comportamento Sexual/estatística & dados numéricos , Parceiros Sexuais , Sífilis/epidemiologia , Tricomoníase/epidemiologia
3.
Am J Trop Med Hyg ; 91(2): 273-80, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24842881

RESUMO

Among human immunodeficiency virus (HIV)-infected adults and children in Africa, diarrheal disease remains a major cause of morbidity and mortality. We evaluated the effectiveness of provision and home-based reinforcement of a point-of-use water filtration device to reduce diarrhea among 361 HIV-infected adults in western Kenya by comparing prevalence of self-reported diarrhea before and after these interventions. After provision of the filter, 8.7% of participants reported diarrhea compared with 17.2% in the 3 months before filter provision (odds ratio [OR] = 0.39, 95% confidence interval [95% CI] = 0.23-0.66, P < 0.001). The association was similar among 231 participants who were already taking daily cotrimoxazole prophylaxis before being given a filter (OR = 0.47, 95% CI = 0.25-0.88, P = 0.019). Educational reinforcement was also associated with a modest reduction in self-reported diarrhea (OR = 0.50, 95% CI = 0.20-0.99, P = 0.047). Provision and reinforcement of water filters may confer significant benefit in reducing diarrhea among HIV-infected persons, even when cotrimoxazole prophylaxis is already being used.


Assuntos
Diarreia/epidemiologia , Diarreia/prevenção & controle , Infecções por HIV/epidemiologia , HIV , Purificação da Água , Adulto , Anti-Infecciosos/uso terapêutico , Coinfecção , Diarreia/microbiologia , Diarreia/parasitologia , Água Potável/microbiologia , Água Potável/parasitologia , Feminino , Filtração , Infecções por HIV/virologia , Humanos , Quênia/epidemiologia , Masculino , Prevalência , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA